文献速递慢性肾脏病肾血管病与高血压

载脂蛋白B、富甘油三酯脂蛋白与CKD患者心血管事件风险

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
PubMed 文献 · Clin J Am Soc Nephrol · 2019-12-12

在9270例CKD患者中,中位随访4.9年,1406例发生动脉粥样硬化性血管事件。apo-B、甘油三酯、TG/HDL比值及富甘油三酯脂蛋白胆固醇每升高1个标准差,动脉粥样硬化性血管事件风险增加,而非动脉粥样硬化性血管事件风险降低。

要点

  • apo-B每升高1个标准差,动脉粥样硬化性血管事件风险增加19%。
  • 甘油三酯、TG/HDL比值、TRL-C升高与动脉粥样硬化性血管事件正相关。
  • 上述脂质指标与非动脉粥样硬化性血管事件呈负相关。

核心结论

  • CKD患者中apo-B、甘油三酯、TG/HDL比值和TRL-C升高与动脉粥样硬化性血管事件风险增加相关。
  • 使用新疗法降低富甘油三酯脂蛋白可能降低CKD人群动脉粥样硬化性心血管疾病风险。

研究设计与样本

  • SHARP研究的事后分析,纳入9270例CKD患者,其中6245例未透析,3025例透析。
  • 采用Cox回归评估血脂与血管事件关联,校正人口学及临床特征。

主要发现

  • 中位随访4.9年,1406例发生至少一次动脉粥样硬化性血管事件。
  • apo-B每升高1个标准差,动脉粥样硬化性血管事件HR为1.19(95%CI 1.12-1.27)。
  • 甘油三酯HR为1.06(95%CI 1.00-1.13),TG/HDL比值HR为1.10(95%CI 1.03-1.18),TRL-C HR为1.14(95%CI 1.05-1.25)。
  • 非动脉粥样硬化性血管事件:apo-B HR为0.92(95%CI 0.85-0.98),甘油三酯HR为0.86(95%CI 0.81-0.92),TG/HDL比值HR为0.88(95%CI 0.82-0.94),TRL-C HR为0.85(95%CI 0.77-0.94)。

临床怎么用

  • 在CKD患者中,可关注apo-B、甘油三酯、TG/HDL比值和TRL-C以评估动脉粥样硬化性血管事件风险。
  • 针对富甘油三酯脂蛋白的新型治疗药物可能为CKD患者降低动脉粥样硬化性心血管风险提供新途径。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Triglyceride-rich lipoproteins may contribute to the high cardiovascular risk of patients with CKD. This study evaluated associations of apo-B and markers of triglyceride-rich lipoproteins with cardiovascular events in people with CKD. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Analyses were conducted in 9270 participants with CKD in the Study of Heart and Renal Protection (SHARP): 6245 not on dialysis (mean eGFR 26.5 ml/min per 1.73 m2), and 3025 on dialysis when recruited. Cox regression methods were used to evaluate associations of lipids with incident atherosclerotic and nonatherosclerotic vascular events, adjusting for demographics and clinical characteristics. Hazard ratios (HRs) were calculated per 1 SD higher level for apo-B, HDL cholesterol, LDL cholesterol, triglyceride-rich lipoprotein cholesterol (i.e., total cholesterol minus LDL cholesterol minus HDL cholesterol), non-HDL cholesterol, log triglyceride, and log ratio of triglyceride to HDL cholesterol. RESULTS: During a median follow-up of 4.9 years (interquartile range, 4.0-5.5 years), 1406 participants experienced at least one atherosclerotic vascular event. In multivariable adjusted models, positive associations with atherosclerotic vascular events were observed for apo-B (HR per 1 SD, 1.19; 95% confidence interval, 1.12 to 1.27), triglycerides (1.06; 1.00 to 1.13), the ratio of triglyceride to HDL cholesterol (1.10; 1.03 to 1.18), and triglyceride-rich lipoprotein cholesterol (1.14; 1.05 to 1.25). By contrast, inverse associations with nonatherosclerotic vascular events were observed for each of these lipid markers: apo-B (HR per 1 SD, 0.92; 0.85 to 0.98), triglycerides (0.86; 0.81 to 0.92), the ratio of triglyceride to HDL cholesterol (0.88; 0.82 to 0.94), and triglyceride-rich lipoprotein cholesterol (0.85; 0.77 to 0.94). CONCLUSIONS: Higher apo-B, triglycerides, ratio of triglyceride to HDL cholesterol, and triglyceride-rich lipoprotein cholesterol concentrations were associated with increased risk of atherosclerotic vascular events in CKD. Reducing triglyceride-rich lipoproteins using novel therapeutic agents could potentially lower the risk of atherosclerotic cardiovascular disease risk in the CKD population.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Lamprea-Montealegre JA, Staplin N, Herrington WG, et al. Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD. Clin J Am Soc Nephrol. 2019. PMID: 31831577. doi:10.2215/CJN.07320619

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。